MICROPX MICRO PELLET DELIVERY SYSTEM
LIVE

Serial Number

79016999

Owner

Glatt GmbH

Attorney

Dionne Heard

Filing Date

Jun 1, 2005

Add to watchlist:

No watchlists yet
View on USPTO

MICROPX MICRO PELLET DELIVERY SYSTEM Trademark

Serial Number: 79016999 • Registration: 3344372

MICROPX MICRO PELLET DELIVERY SYSTEM is a trademark filed by Glatt GmbH on June 1, 2005. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Glatt GmbH (23 trademarks)

Binzen 79589 , DE

Entity Type: 99

Trademark Details

Filing Date

June 1, 2005

Registration Date

November 27, 2007

Published for Opposition

September 11, 2007

Goods & Services

[ Rental of devices and machines to third parties, namely, fluid bed machines and spray dry granulators for use in granulating, pelletizing, drying, coating, agglomerating medicines and medicaments for solid and oral dosage forms, except those used in the manufacture of pyridoxine or those used in the treatment of pyridoxine ]

[ Pharmaceutical preparations for the treatment, including prophylactic treatment, of disorders of the Central Nervous System (CNS), namely, psychopharmacologic drugs, soporifics, analeptics, analgetics, local anesthetics, general anesthetics, myorelaxants, anti-epileptics, anticonvulsants, antiparkinsonian agents, anti-emetics, sympathomimetics and/or parasympathomimetics; disorders of the hormonal system, namely, hypothalamic hormones, anterior pituitary hormones, therapeutics for thyroid disorders, therapeutics for diabetes, therapeutics for disorders of the adrenal cortex, sexual hormones and/or antihistaminics; disorders of the cardiovascular system, namely, drugs for the treatment of blood diseases, insufficiency of the heart, diseases of the vascular system, other heart diseases and/or hypertonia; disorders of the respiratory system, namely, anti-asthmatics and/or antitussives; disorders of the gastro-intestinal tract, namely, antacids, prokinetics, ulcus drugs, drugs for the treatment of Colitis ulcerosa and Crohn's disease, drugs for the treatment of obstipation, drugs for the treatment of diarrhoea, choleretics or cholagogues, other hepatotherapeutics and/or contrast media; renal and urinary tract disorders, namely, diuretics or antidiuretics; dermal disorders, namely, dermatotherapeutics; micronutrients, vitamins and/or trace elements; infectious diseases, namely, disinfectants and/or anti-infectives; cancer diseases, namely, antimetabolites, antibiotics with cytostatic effect, other cytostatics, and/or hormones and hormone antagonists; disorders of the immune system, namely, immunosuppressives or other immunomodulators ]

Scientific research and development of technologies for the manufacture of pharmaceuticals

Filing History

INTERNATIONAL REGISTRATION RENEWED
Jun 26, 2025 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Oct 11, 2019 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 16, 2018 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 7, 2018 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 7, 2017 NA71
REGISTERED-SEC.71 ACCEPTED
Jul 7, 2017 71AG
TEAS SECTION 71 RECEIVED
Jul 5, 2017 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 27, 2016 REM4
PARTIAL INVALIDATION PROCESSED BY THE IB
Jun 19, 2015 INNP
INTERNATIONAL REGISTRATION RENEWED
Jun 18, 2015 RNWL
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 6, 2015 INPS
INVALIDATION PROCESSED
Feb 6, 2015 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 12, 2014 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 11, 2013 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 11, 2013 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 11, 2013 APRE
REGISTERED - SEC. 71 & SEC. 15 FILED
Nov 27, 2013 715F
TEAS SECTION 71 & 15 RECEIVED
Nov 27, 2013 ES75
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 12, 2009 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 12, 2008 FICS
FINAL DISPOSITION PROCESSED
Mar 12, 2008 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 27, 2008 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 27, 2007 R.PR
PUBLISHED FOR OPPOSITION
Sep 11, 2007 PUBO
NOTICE OF PUBLICATION
Aug 22, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 6, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2007 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2007 CRFA
ASSIGNED TO LIE
May 18, 2007 ALIE
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 10, 2007 OPNX
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2007 TROA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 26, 2007 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 26, 2007 OPNR
FINAL REFUSAL MAILED
Oct 30, 2006 CNFR
FINAL REFUSAL WRITTEN
Oct 27, 2006 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2006 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 5, 2006 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 5, 2006 REAP
REFUSAL PROCESSED BY IB
Jan 27, 2006 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 9, 2006 RFCS
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 22, 2005 RFCR
NON-FINAL ACTION WRITTEN
Dec 21, 2005 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2005 DOCK
NEW APPLICATION ENTERED
Nov 30, 2005 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 28, 2005 REPR